Related Experiment Video
Updated: Jul 10, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
The Multifunctional Nature of the MicroRNA/AKT3 Regulatory Axis in Human Cancers
Chun Yang1, Pierre Hardy1,2
1Research Center of CHU Sainte-Justine, University of Montréal, Montreal, QC H3T 1C5, Canada.
Abstract:
Serine/threonine kinase (AKT) signaling regulates diverse cellular processes and is one of the most important aberrant cell survival mechanisms associated with tumorigenesis, metastasis, and chemoresistance. Targeting AKT has become an effective therapeutic strategy for the treatment of many cancers. AKT3 (PKBγ), the least studied isoform of the AKT family, has emerged as a major contributor to malignancy. AKT3 is frequently overexpressed in human cancers, and many regulatory oncogenic or tumor suppressor small non-coding RNAs (ncRNAs), including microRNAs (miRNAs), have recently been identified to be involved in regulating AKT3 expression. Therefore, a better understanding of regulatory miRNA/AKT3 networks may reveal novel biomarkers for the diagnosis of patients with cancer and may provide invaluable information for developing more effective therapeutic strategies. The aim of this review was to summarize current research progress in the isoform-specific functions of AKT3 in human cancers and the roles of dysregulated miRNA/AKT3 in specific types of human cancers.
Insights
The AKT3 protein, a key regulator in cancer, is controlled by microRNAs (miRNAs). Understanding these miRNA/AKT3 networks can lead to new cancer biomarkers and treatments.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Serine/threonine kinase (AKT) signaling pathways are crucial in cell survival, proliferation, and are frequently dysregulated in cancer, driving tumorigenesis, metastasis, and chemoresistance.
- Targeting AKT signaling represents a significant therapeutic strategy in oncology.
- AKT3 (PKBγ), the least studied AKT isoform, plays a critical role in cancer malignancy, with its expression often elevated in various human cancers.
Purpose of the Study:
- To review the current understanding of AKT3's isoform-specific functions in human cancers.
- To summarize the roles of dysregulated microRNA (miRNA)/AKT3 interactions in the context of specific human cancers.
- To highlight the potential of miRNA/AKT3 networks as diagnostic biomarkers and therapeutic targets.
Main Methods:
- Literature review and synthesis of existing research on AKT3 and its regulatory miRNAs in cancer.
- Analysis of studies investigating AKT3 overexpression and its oncogenic roles.
- Examination of identified miRNA regulatory mechanisms targeting AKT3 expression.
Main Results:
- AKT3 is frequently overexpressed in human cancers, contributing significantly to malignant progression.
- Numerous oncogenic and tumor suppressor small non-coding RNAs, particularly miRNAs, have been identified as regulators of AKT3 expression.
- Dysregulation of specific miRNA/AKT3 networks is implicated in the pathogenesis of various cancer types.
Conclusions:
- AKT3 is a critical mediator of cancer malignancy, with its expression tightly regulated by miRNAs.
- Understanding the intricate miRNA/AKT3 regulatory networks is essential for identifying novel cancer biomarkers.
- Targeting these miRNA/AKT3 interactions holds promise for developing more effective cancer therapies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
lncRNA - Long Non-coding RNAs
Abnormal Proliferation

